Cryoserv (dimethyl sulfoxide)
Miscellaneous Vial (ML)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Generic name: dimethyl sulfoxide
Therapeutic class: Chemicals-Pharmaceutical Adjuvants
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Cryoserv
Indications
No indications are available for this drug.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
Contraindicated Drug Combination: This drug combination is contraindicated and generally should not be dispensed or administered to the same patient.
Dimethyl Sulfoxide (DMSO)/Sulindac
SEVERITY LEVEL: 1-Contraindicated Drug Combination: This drug combination is contraindicated and generally should not be dispensed or administered to the same patient.
MECHANISM OF ACTION: Dimethyl sulfoxide (DMSO) inhibits the bioactivation of sulindac to its active metabolite.(1,2)
CLINICAL EFFECTS: Concurrent use of DMSO may result in decreased effectiveness of sulindac(1,2) and peripheral neuropathy.(1,3,4)
PREDISPOSING FACTORS: None determined.
PATIENT MANAGEMENT: The US manufacturer of sulindac states that DMSO should not be used with sulindac.(1)
DISCUSSION: In a study in 8 healthy male subjects, pretreatment with an oral dose of DMSO (30 ml of a 70% solution) 60 minutes before a single dose of sulindac (400 mg) decreased concentrations of the active sulfide metabolite of sulindac at 1.5, 2, 3, 4, 8, and 12 hours post dose. The area-under-curve (AUC) of the active sulfide metabolite was 30% lower (range 7% to 56%).(2) There are case reports of peripheral neuropathy during the concurrent use of sulindac and DMSO,(1,3,4) including one report with topical use of DMSO.(3)
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
Less Frequent
- Anaphylaxis
- Angioedema
- Bronchospastic pulmonary disease
- Dermatitis due to topical drug
- Dyspnea
- Nasal congestion
- Pruritus of skin
- Skin rash
- Urticaria
Less Frequent
- Body odor
- Dysgeusia
- Halitosis
- Injection site sequelae
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.